The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
16 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,650,968 in first-year total cost, median $221,703.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC]15
- Special Emphasis Panel[ZAR1 KM (M2)]1
Most frequent institutions
- CLEVELAND CLINIC LERNER COM-CWRU2
- INDIANA UNIVERSITY INDIANAPOLIS2
- CHILDREN'S HOSP OF PHILADELPHIA1
- EMORY UNIVERSITY1
- OHIO UNIVERSITY ATHENS1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Establishing The Validity, Responsiveness, And Appropriateness Of Patient-Reported Outcome Measures For Adult Traumatic Brachial Plexus Injury1R01AR079139-01 | DY, CHRISTOPHER JOHN | WASHINGTON UNIVERSITY, MO | $254,388 | AMSC |
| 2021 | Addressing knowledge gaps by multi-level research design to optimize clinical trial development in order to reduce fracture burden for adults with neurodevelopmental disabilities1R01AR076994-01A1 | WHITNEY, DANIEL | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $240,240 | AMSC |
| 2021 | Discovery of the Neural Drivers Underlying Injury-Risk Biomechanics1R01AR077248-01A1 | GROOMS, DUSTIN ROBERT | OHIO UNIVERSITY ATHENS, OH | $223,976 | ZAR1 |
| 2021 | Flare assessment for hidradenitis suppurativa1R01AR077122-01A1 | KIRBY, JOSLYN S | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $214,078 | AMSC |
| 2021 | Effects of biologic and targeted therapies for rheumatoid arthritis on cancer outcomes1R01AR078484-01A1 | GIORDANO, SHARON HERMESSUAREZ-ALMAZOR, MARIA E | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $213,840 | AMSC |
| 2021 | Helping patients and physicians choose the appropriate surgery for end stage hallux rigidus1R01AR078487-01 | NORVELL, DANIEL CSANGEORZAN, BRUCE | SEATTLE INST FOR BIOMEDICAL/CLINICAL RES, WA | $209,748 | AMSC |
| 2020 | Understanding the Global Burden of Disease of Skeletal Fractures: the International Orthopaedic Multi-Center Study (INORMUS)1R01AR076654-01 | BHANDARI, MOHITMICLAU, THEODORE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $296,539 | AMSC |
| 2020 | Sarcopenia: computable phenotypes and clinical outcomes.1R01AR077273-01 | IMEL, ERIK ALLEN | INDIANA UNIVERSITY INDIANAPOLIS, IN | $235,788 | AMSC |
| 2020 | The Natural History of Autosomal Dominant Osteopetrosis Type 21R01AR077869-01 | ECONS, MICHAEL J | INDIANA UNIVERSITY INDIANAPOLIS, IN | $219,429 | AMSC |
| 2020 | Improving Clinical Trial Recruitment and Outcome Measures in Bullous Pemphigoid1R01AR076089-01A1 | FELDMAN, RON | EMORY UNIVERSITY, GA | $205,920 | AMSC |
| 2020 | Development of MRI, Alternative Splicing, and Functional Abilities asBiomarkers in Myotonic Dystrophy Type 11R01AR076060-01A1 | LOTT, DONOVAN J | UNIVERSITY OF FLORIDA, FL | $182,137 | AMSC |
| 2020 | Identifying the patient, disease, surgical, and implant positional shift factors that predict outcomes following total shoulder arthroplasty1R01AR075286-01A1 | RICCHETTI, ERIC T. | CLEVELAND CLINIC LERNER COM-CWRU, OH | $172,681 | AMSC |
| 2019 | Refining entry criteria and outcome measures for children with axial disease and spondyloarthritis: preparation for clinical trials1R01AR074098-01A1 | WEISS, PAMELA FITCH | CHILDREN'S HOSP OF PHILADELPHIA, PA | $303,188 | AMSC |
| 2019 | Total-Body PET/CT for assessing Rheumatoid Arthritis Disease Activity and Treatment Response1R01AR076088-01 | CHAUDHARI, ABHIJIT J | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $241,780 | AMSC |
| 2019 | Refining outcome measures through observational cohorts to advance trials in morphea1R01AR073516-01A1 | JACOBE, HEIDI TTOROK, KATHRYN S. | UT SOUTHWESTERN MEDICAL CENTER, TX | $225,926 | AMSC |
| 2019 | MRI Predictors of Outcome after Arthroscopic Partial Meniscectomy1R01AR073512-01A1 | SUBHAS, NAVEEN | CLEVELAND CLINIC LERNER COM-CWRU, OH | $211,310 | AMSC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.